Alimera Sciences reported $17.01M in Operating Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbvie ABBV:US USD 10.21B 1.08B
Alimera Sciences ALIM:US USD 17.01M 431K
Bayer BAYN:GR EUR 10.08B 2.57B
Insmed INSM:US USD 195.43M 41.89M
Novartis NOVN:VX USD 10.67B 183M
Ophthotech OPHT:US USD 42.51M 7.24M
Regeneron Pharmaceuticals REGN:US USD 1.71B 34.8M
Roche Holding ROG:VX 20.75B 3.26B